Loading...
Uscom Limited
UCM.AX•ASX
Healthcare
Medical - Devices
A$0.01
A$0.00(0.00%)
Uscom Limited (UCM.AX) Financial Performance & Income Statement Overview
Explore the financials of Uscom Limited (UCM.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
39.89%
↑ 39.89%
Operating Income Growth
17.56%
↑ 17.56%
Net Income Growth
19.92%
↑ 19.92%
Operating Cash Flow Growth
18.30%
↑ 18.30%
Operating Margin
-74.28%
↓ 74.28%
Gross Margin
83.60%
↑ 83.60%
Net Profit Margin
-65.07%
↓ 65.07%
ROE
-95.61%
↓ 95.61%
ROIC
-107.30%
↓ 107.30%
Uscom Limited (UCM.AX) Income Statement & Financial Overview
Review Uscom Limited UCM.AX income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.77M | $1.71M | $1.64M | $1.02M |
| Cost of Revenue | $361777.00 | $1.88M | $2.04M | $1.65M |
| Gross Profit | $1.41M | -$174310.00 | -$392733.00 | -$633073.00 |
| Gross Profit Ratio | $0.80 | -$0.10 | -$0.24 | -$0.62 |
| R&D Expenses | $13869.00 | $8074.00 | $9729.00 | $38863.00 |
| SG&A Expenses | $2.96M | $898470.00 | $939068.00 | $903031.00 |
| Operating Expenses | $2.97M | $906544.00 | $948797.00 | $941894.00 |
| Total Costs & Expenses | $3.33M | $2.79M | $2.98M | $2.60M |
| Interest Income | $40546.00 | $5497.00 | $34468.00 | $20915.00 |
| Interest Expense | $88114.00 | $43411.00 | $77784.00 | $25133.00 |
| Depreciation & Amortization | $68378.00 | $192196.00 | $188541.00 | $194133.00 |
| EBITDA | -$1.04M | -$642921.00 | -$913802.00 | -$1.16M |
| EBITDA Ratio | -$0.59 | -$0.52 | -$0.70 | -$1.35 |
| Operating Income | -$1.56M | -$1.08M | -$1.34M | -$1.57M |
| Operating Income Ratio | -$0.88 | -$0.63 | -$0.82 | -$1.54 |
| Other Income/Expenses (Net) | $412364.00 | $202323.00 | $161399.00 | $198473.00 |
| Income Before Tax | -$1.15M | -$878527.00 | -$1.18M | -$1.38M |
| Income Before Tax Ratio | -$0.65 | -$0.51 | -$0.72 | -$1.35 |
| Income Tax Expense | $25287.00 | $22140.00 | $19295.00 | $14965.00 |
| Net Income | -$1.17M | -$900667.00 | -$1.20M | -$1.39M |
| Net Income Ratio | -$0.66 | -$0.53 | -$0.73 | -$1.36 |
| EPS | -$0.007 | -$0.005 | -$0.006 | -$0.007 |
| Diluted EPS | -$0.007 | -$0.005 | -$0.006 | -$0.007 |
| Weighted Avg Shares Outstanding | $167.15M | $190.53M | $187.37M | $198.64M |
| Weighted Avg Shares Outstanding (Diluted) | $175.85M | $190.53M | $187.37M | $198.64M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan